It was an interesting week for the markets as we saw the S&P 500 test the 3700 psychological level. Buyers were hesitant at these levels which led to some profit taking late in the week. Sentiment suggests a near term bullish top that may need a few sessions of consolidation. The macro backdrop remained muddled as Capitol Hill fought over stimulus and budget bills. COVID figures continued to rise but Pfizer’s (PFE) vaccine received emergency use authorization from the FDA. Plenty of noise to provide distractions but, let us review stocks your clients were researching while these macro stories garnered the headlines.
- Trivia Question- The oncology market covers every area of cancer and is one of the biggest sectors in the life science space. Can you name the oncology company that has the biggest market cap? (Answer Below)
It was a busy week on the IPO front with highly anticipated debuts by DoorDash (DASH) and Airbnb (ABNB). Both stocks surged above the IPO pricing range as investors flocked into the names. We were surprised that neither stock made its way on to Retail lists. Another IPO, C3.AI (AI), came in at #10 in the Top Stocks by Retail- Surge* Traffic list. The company, run by Silicon Valley legend Thomas Siebel, allows companies to develop, test and run full-scale, real-time enterprise AI applications. It priced 15.5 mln shares at $42 which was above the expected range of $31-34 and opened for trade at $100.
TrackStarIQ Data
Here are some highlights from Retail searches this week –
| Rank | TOP STOCKS – BY Retail (Total Traffic) This Past Week | Ticker | TOP STOCKS- BY RETAIL (Surge Traffic) This Past Week | Ticker | TOP ETFs By RETAIL (Total Traffic) This Past Week |
|---|---|---|---|---|---|
| 1 | Tesla Inc | TSLA | Greenwich Lifesciences Inc | GLSI | MLCX Grains ETN |
| 2 | Nio Inc | NIO | Immutep Ltd ADR | IMMP | Innovation Shares NextGen Protocol ETF |
| 3 | Greenwich Lifesciences Inc | GLSI | Silver Spike Acquisition Corp Cl A | SSPK | SPDR S&P 600 Small Cap ETF |
| 4 | Apple Inc | AAPL | Dominion Energy Midstream Partners LP | DM | RICI-Total Return ETN |
| 5 | Pfizer Inc | PFE | Xenetic Biosciences Inc | XBIO | Vanguard Short-Term Corporate Bond ETF |
| 6 | Sundial Growers Inc | SNDL | Utstarcom Holdings C | UTSI | First Trust ISE Water Index Fund |
| 7 | Tesoro Enterprises, Inc. | TSNP | Rocket Pharmaceuticals Inc | RCKT | Breakwave Dry Bulk Shipping ETF |
| 8 | Eastman Kodak | KODK | Veru Inc | VERU | Loncar Cancer Immunotherapy ETF |
| 9 | Curis Inc | CRIS | Arcis Resources Corporation | ARCS | Franklin FTSE South Korea ETF |
| 10 | Eversource Energy | ES | Arlington Asset Investment Corp | AI | First Trust ISE-Revere Natural Gas Index Fund |
| 11 | Amazon.com Inc | AMZN | Sellas Life Sciences Group Inc | SLS | Invesco CurrencyShares? Swiss Franc Trust |
| 12 | Sellas Life Sciences Group Inc | SLS | Chinanet Online Hld | CNET | Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF |
| 13 | Immutep Ltd ADR | IMMP | Neos Therapeutics | NEOS | ProShares S&P 500 Ex-Energy ETF |
| 14 | AT&T Inc | T | Data Call Technologies, Inc. | DCLT | iShares S&P Asia ETF |
| 15 | Gamestop Corp | GME | GeoVax Labs, Inc. | GOVX | Reality Shares Nasdaq NexGen Economy ETF |
| 16 | Moderna Inc | MRNA | Entera Bio Ltd | ENTX | Direxion Daily Retail Bull 3X Shares |
| 17 | Ideanomics Inc | IDEX | M T S Systems Cp | MTSC | JPMorgan BetaBuilders Japan ETF |
| 18 | Virgin Galactic Holdings Inc | SPCE | Qiwi Plc ADR | QIWI | Global X Genomics & Biotechnology ETF |
| 19 | Sorrento Therpt | SRNE | Cypress Energy Partners LP | CELP | Vanguard Growth ETF |
| 20 | Visa Inc | V | Cardtronics Inc | CATM | iShares Convertible Bond ETF |
*- Surge data is based on the average traffic from the past two days compared to the average traffic from the previous market week.
IPOs were not the only area to garner attention by your clients as Biotechnology was a hot space. This week we saw an increased interest from retail clients around cancer treatment. The American Association for Cancer Research held its annual San Antonio Breast Cancer Symposium (SABCS) under virtual conditions. The research studies announced by companies are critical in fighting this terrible disease. Retail was certainly focused on the announcements as the space produced some of this week’s biggest winners including:
- Greenwich Lifescience (GLSI)– #3 in Top Stocks by Retail Total Traffic and #1 in Top Stocks by Retail Surge Traffic. The GP2 Phase III clinical trial design saw positive data from its trial. The stock has a miniscule float of 1.74 mln so it saw shares skyrocket from the $6 area to $150 in reaction to the news before cooling off and settling back down around $50 to end the week.
- Immutep (IMMP)- #13 in Top Stocks by Retail Total Traffic and #2 in Top Stocks by retail Surge Traffic. Shares of the company tripled from $2.05 to $7.95 after it announced positive results from a trial for its treatment for metastatic breast cancer. The float is larger than GLSI at 46 mln. The stock has given up half of its gains to slip back to $3.60.
- Curis (CRIS)- #9 in Top Stocks by Retail Total Traffic. CRIS shares rallied following an update from its ongoing Phase 1 study for the treatment of patients with relapsed or refractory non-Hodgkin’s lymphoma.
Trivia Answer- NovoCure (NVCR) at $11.42 bln has the biggest market cap for pure-play oncology names. NVCR is a commercial-stage oncology company pioneering a novel therapy for solid tumors called Tumor Treating Fields. Other major oncology names include: Guardant Health (GH), Mirati Therapeutics (MRTX), Iovance Biotherapeutics (IOVA), Berkeley Lights (BLI), and Burning Rock Biotech (BNR).